Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Cash & Current Investments (2010 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Cash & Current Investments of $314.7 million for Q2 2026, up 5.35% year-over-year from $298.7 million in Q2 2025, and up 2.21% quarter-over-quarter from $307.9 million in Q1 2026.

Amarin Corp Plcuk (AMRN) Cash & Current Investments (2010 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Cash & Current Investments for 17 consecutive years, with $314.7 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash & Current Investments rose 5.35% year-over-year to $314.7 million; the TTM figure through Jun 2026 stood at $314.7 million (up 5.35% YoY), while the FY2025 annual figure was $302.6 million, up 2.84% from the prior year.
  • Cash & Current Investments improved to $314.7 million in Q2 2026 per AMRN's latest filing, from $307.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $362.6 million in Q1 2022 and bottomed at $281.8 million in Q1 2025.
  • Historically, Cash & Current Investments has averaged $308.6 million across 5 years, with a median of $307.3 million in 2024.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 38.45% — and 2026, when it gained 9.25%.
  • Amarin Corp Plc\Uk's Cash & Current Investments stood at $309.4 million in 2022, then climbed by 3.65% to $320.7 million in 2023, then slipped by 8.25% to $294.2 million in 2024, then gained by 2.84% to $302.6 million in 2025, then gained by 4.0% to $314.7 million in 2026.
  • Business Quant data shows AMRN's Cash & Current Investments at $314.7 million in Q2 2026, $307.9 million in Q1 2026, and $302.6 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 20.76 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 6.57 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 7.69 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 4.90 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 3.18 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 11.70 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 4.17 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn 314.70 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 314.70 Mn
Mar 31, 2026 307.90 Mn
Dec 31, 2025 302.59 Mn
Sep 30, 2025 286.60 Mn
Jun 30, 2025 298.73 Mn
Mar 31, 2025 281.82 Mn
Dec 31, 2024 294.22 Mn
Sep 30, 2024 305.74 Mn
Jun 30, 2024 306.66 Mn
Mar 31, 2024 308.18 Mn
Dec 31, 2023 320.66 Mn
Sep 30, 2023 320.66 Mn
Jun 30, 2023 312.92 Mn
Mar 31, 2023 304.41 Mn
Dec 31, 2022 309.36 Mn
Sep 30, 2022 303.70 Mn
Jun 30, 2022 313.23 Mn
Mar 31, 2022 362.61 Mn
Dec 31, 2021 454.13 Mn
Sep 30, 2021 479.20 Mn